Pertti Lipponen
Impact in
- Cell Biology top 5%
- Proteoglycans and glycosaminoglycans research
- Cancer Research top 10%
- Breast Cancer Treatment Studies
Papers in
-
- Breast Cancer Treatment Studies 17
- Oncology 7
- Pancreatic and Hepatic Oncology Research 2
- HER2/EGFR in Cancer Research 2
- Co-authors
- Kari Juhani Syrjänen (22 shared papers)Sirpa H. Aaltomaa (17 shared papers)E. M. ALHAVA (14 shared papers)Raija Tammi (2 shared papers)Markku Tammi (2 shared papers)V‐M Kosma (2 shared papers)Kirsi M. Ropponen (2 shared papers)Jyrki J. Parkkinen (1 shared paper)
- Journals
- European Urology (2 papers)British Journal of Cancer (2 papers)Oncology (2 papers)International Journal of Oncology (1 paper)The American Journal of Surgery (1 paper)
- Partner nations
- Finland
In The Last Decade
Pertti Lipponen
34 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 69
- Cell Biology 260
- Cancer Research 190
- Oncology 192
- Pulmonary and Respiratory Medicine 184
- Otorhinolaryngology 23
Countries citing papers authored by Pertti Lipponen
This map shows the geographic impact of Pertti Lipponen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pertti Lipponen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pertti Lipponen more than expected).
Fields of papers citing papers by Pertti Lipponen
This network shows the impact of papers produced by Pertti Lipponen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pertti Lipponen. The network helps show where Pertti Lipponen may publish in the future.
Co-authors
The 25 scholars most cited alongside Pertti Lipponen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. | 1998 | 300 |
| 2 | Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer. | 2001 | 90 |
| 3 | 1996 | 81 | |
| 4 | 1999 | 73 | |
| 5 | 2002 | 71 | |
| 6 | Mast cells in breast cancer. | 1993 | 65 |
| 7 | Tumor vascularity and basement membrane structure as prognostic factors in T1-2MO prostatic adenocarcinoma. | 1994 | 58 |
| 8 | 1992 | 44 | |
| 9 | Proliferating cell nuclear antigen (PCNA) immunolabeling as a prognostic factor in axillary lymph node negative breast cancer. | 1993 | 43 |
| 10 | 1991 | 42 | |
| 11 | Expression of c-myc proteins in breast cancer as related to established prognostic factors and survival. | 1995 | 31 |
| 12 | Prognostic value of cell proliferation in breast cancer as determined by proliferating cell nuclear antigen (PCNA) immunostaining. | 1992 | 26 |
| 13 | Prognostic significance of TGF-beta 1 and TGF-beta 2 expressions in female breast cancer. | 1996 | 24 |
| 14 | Mitotic activity index, volume corrected mitotic index and human papilloma-virus suggestive morphology are not prognostic factors in carcinoma of the oesophagus. | 1993 | 21 |
| 15 | Prognostic value of cathepsin-D expression in female breast cancer. | 1995 | 18 |
| 16 | Comparison of classic and quantitative prognostic factors in colorectal cancer. | 1997 | 17 |
| 17 | Nuclear morphometry and DNA flow cytometry as prognostic factors in female breast cancer. | 1992 | 15 |
| 18 | 1991 | 14 | |
| 19 | Expression of epidermal growth factor receptor (EGFR) in breast cancer as related to clinical, prognostic and cytometric factors. | 1996 | 14 |
| 20 | 1992 | 12 |
About Pertti Lipponen
Pertti Lipponen is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Cell Biology and Pathology and Forensic Medicine, having authored 34 papers that have together received 1.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (17 papers), Prostate Cancer Diagnosis and Treatment (5 papers), Prostate Cancer Treatment and Research (4 papers), Proteoglycans and glycosaminoglycans research (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Breast Lesions and Carcinomas (2 papers), HER2/EGFR in Cancer Research (2 papers) and AI in cancer detection (1 paper). The work is most often cited by research in Cell Biology (260 citations), Cancer Research (190 citations), Oncology (192 citations), Pulmonary and Respiratory Medicine (184 citations) and Otorhinolaryngology (23 citations). Pertti Lipponen has collaborated with scholars based in Finland. Frequent co-authors include Kari Juhani Syrjänen, Sirpa H. Aaltomaa, E. M. ALHAVA, Raija Tammi, Markku Tammi, V‐M Kosma, Kirsi M. Ropponen, Jyrki J. Parkkinen, Ulla M. Ågren and S. Marin. Their work appears in journals such as European Urology, British Journal of Cancer, Oncology, International Journal of Oncology and The American Journal of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.